There are no antiviral therapies or vaccines that have been developed using zinc finger protein yet, but we expect the potential of CCCH-type and CCHC-type zinc finger proteins as antiviral therapy and vaccine candidates to protect human and animal populations from virus infection and to suppress cancer with the understanding of the characteristics of zinc finger protein mentioned in this review. This evidence concerns the gene ZNF146 and viral infectious disease.